iBio
IBIO
13 hedge funds and large institutions have $275K invested in iBio in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.
30% more funds holding
Funds holding: 10 → 13 (+3)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
30% less capital invested
Capital invested by funds: $393K → $275K (-$118K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
+$15.4K |
| 2 |
VF
Virtu Financial
New York
|
+$8.1K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$2.02K |
| 4 |
BlackRock
New York
|
+$405 |
Top Sellers
| 1 |
S
SignatureFD
Atlanta,
Georgia
|
-$111K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$4.45K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.02K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$405 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $150K | -$2.02K | -5 | -1% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $29K | – | – | – |
|
|
TSS
3
Two Sigma Securities
New York
| $16K | +$15.4K | +38 | New |
|
|
4
BlackRock
New York
| $14K | +$405 | +1 | +3% |
|
|
S
5
SignatureFD
Atlanta,
Georgia
| $13K | -$111K | -275 | -90% |
|
6
HighTower Advisors
Chicago,
Illinois
| $12K | – | – | – |
|
7
Northern Trust
Chicago,
Illinois
| $12K | – | – | – |
|
|
VF
8
Virtu Financial
New York
| $9K | +$8.1K | +20 | New |
|
|
PAM
9
Panagora Asset Management
Boston,
Massachusetts
| $7K | -$4.45K | -11 | -41% |
|
|
10
UBS Group
Zurich,
Switzerland
| $7K | -$405 | -1 | -6% |
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
12
Bank of America
Charlotte,
North Carolina
| $2K | +$2.02K | +5 | New |
|
13
Morgan Stanley
New York
| $1K | – | – | – |
|
|
PFGIA
14
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
| $1K | – | – | – |
|
IBIO Hedge Fund Activity: Q3 2018 in Review
13 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q3 2018, worth a combined $275K — down 30% from $393K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IBIO positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $15.4K. The largest seller was SignatureFD, cutting an estimated $111K.
- 13 institutional investors held iBio (IBIO) as of Q3 2018, up from 10 in Q2 2018.
- Funds reported $275K of iBio stock for Q3 2018, down 30% quarter-over-quarter.
- 3 funds opened new iBio positions in Q3 2018 and 0 closed out, a net change of +3 holders.
- The largest iBio buyer in Q3 2018 was Two Sigma Securities, an estimated $15.4K added.
- The largest iBio seller in Q3 2018 was SignatureFD, an estimated $111K sold.
Based on aggregated 13F filings for Q3 2018.